Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180), Unconjugated

Produktübersicht

• Artikelname: Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180), Unconjugated
• Artikelnummer: ABS-SPD-M180-100UG
• Hersteller Artikelnummer: SPD-M180-100ug
• Alternativnummer: ABS-SPD-M180-100UG
• Hersteller: AcroBiosystems
• Wirt: Human
• Kategorie: Antikörper
• Spezies Reaktivität: Human
• Konjugation: Unconjugated

Produktbeschreibung

AntiSARSCoV2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) is isolated from a SARSCoV2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARSCoV2 Spike Protein RBD domain and inhibits the interaction between SARSCoV2 RBD and ACE2 with an IC50 of 0.98 µg/mL using SARSCoV2 Inhibitor Screening Kit.Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARSCoV2 Spike protein. - Antikörper

Produkteigenschaften

• Tag: Human IgG1 | Human Kappa
• Puffer: PBS, pH7.4
• Reinheit: 0.95
• Formulierung: Powder
• Target-Kategorie: Spike RBD

Bilder

Immobilized SARS-CoV-2 S protein RBD, His Tag (Cat. No. SPD-C52H3) at 1 µg/mL (100 µL/well) can bind Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) (Cat. No. SPD-M180) with a linear range of 0.2-2 ng/mL (QC tested).

Serial dilutions of Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) (Cat. No. SPD-M180) were added into SARS-CoV-2 S protein RBD, His Tag (Cat. No. SPD-C52H3): Biotinylated Human ACE2, His,Avitag (Cat. No. AC2-H82E6) binding reactions. The half maximal inhibitory concentration (IC50) is 0.98269 µg/mL (Routinely tested).

Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 0.95.